855 filings
PRE 14A
BGNE
BeiGene Ltd
Preliminary proxy
15 Apr 24
4:27pm
4
BGNE
BeiGene Ltd
11 Apr 24
BeiGene / JOHN OYLER ownership change
6:01pm
144
BGNE
BeiGene Ltd
9 Apr 24
Notice of proposed sale of securities
4:21pm
3
Titus B. Ball
26 Mar 24
BeiGene / Titus B. Ball ownership change
5:26pm
144
BGNE
BeiGene Ltd
26 Mar 24
Notice of proposed sale of securities
4:19pm
8-K
b1km 0nfp
20 Mar 24
Departure of Directors or Certain Officers
4:10pm
8-K
w3xsecjg1 gh0
15 Mar 24
BeiGene Receives FDA Approval for TEVIMBRA® for the Treatment of Advanced or Metastatic Esophageal Squamous Cell Carcinoma After Prior Chemotherapy
4:52pm
4
niv6 crabkh0dm9k
14 Mar 24
BeiGene / JOHN OYLER ownership change
5:23pm
4
z8ag5q
13 Mar 24
BeiGene / Donald W. Glazer ownership change
5:04pm
144
so91kms055wmg
12 Mar 24
Notice of proposed sale of securities
4:28pm
8-K
dgs3uc0l98 6m0ql0
8 Mar 24
Other Events
6:01am
4
k1rh14a
4 Mar 24
BeiGene / OLIVIER BRANDICOURT ownership change
5:24pm
4
00se 1izqlk9
4 Mar 24
BeiGene / Julia Aijun Wang ownership change
5:22pm
144
q77onu1md u8ti
29 Feb 24
Notice of proposed sale of securities
4:27pm
8-K
hhs4h l71qk
26 Feb 24
BeiGene Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
6:02am
SC 13G/A
4h65phv1ceh974va
9 Feb 24
BeiGene / Capital International Investors ownership change
6:03pm
SC 13G/A
ozisss
5 Feb 24
BeiGene / OYLER JOHN ownership change
4:12pm
3
9oxdhe
23 Jan 24
BeiGene / OLIVIER BRANDICOURT ownership change
5:02pm
8-K
fhbvx7j bkt
23 Jan 24
BeiGene Welcomes Experienced Life Sciences Executive Olivier Brandicourt to Board of Directors
6:03am